155 related articles for article (PubMed ID: 26517961)
21. A novel radiopharmaceutical for detection of malignant melanoma, based on melanin formation: 3-iodo-4-hydroxyphenyl-L-cysteine.
Nishii R; Kawai K; Garcia Flores L; Kataoka H; Jinnouchi S; Nagamachi S; Arano Y; Tamura S
Nucl Med Commun; 2003 May; 24(5):575-82. PubMed ID: 12717077
[TBL] [Abstract][Full Text] [Related]
22. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Achten E; Dierckx RA; Mertens J; Slegers G
J Nucl Med; 2005 Mar; 46(3):532-9. PubMed ID: 15750170
[TBL] [Abstract][Full Text] [Related]
23. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N
Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663
[TBL] [Abstract][Full Text] [Related]
24. Radioiodinated methylene blue--a promising agent for melanoma scintigraphy: labelling, stability and in vitro uptake by melanoma cells.
Sobal G; Rodrigues M; Sinzinger H
Anticancer Res; 2008; 28(6A):3691-6. PubMed ID: 19189650
[TBL] [Abstract][Full Text] [Related]
25. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
[TBL] [Abstract][Full Text] [Related]
26. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma.
Brandau W; Niehoff T; Pulawski P; Jonas M; Dutschka K; Sciuk J; Coenen HH; Schober O
J Nucl Med; 1996 Nov; 37(11):1865-71. PubMed ID: 8917194
[TBL] [Abstract][Full Text] [Related]
27. Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.
Rbah-Vidal L; Vidal A; Billaud EM; Besse S; Ranchon-Cole I; Mishellany F; Perrot Y; Maigne L; Moins N; Guerquin-Kern JL; Degoul F; Chezal JM; Auzeloux P; Miot-Noirault E
Neoplasia; 2017 Jan; 19(1):17-27. PubMed ID: 27987437
[TBL] [Abstract][Full Text] [Related]
28. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
29. Melanin-targeted preclinical PET imaging of melanoma metastasis.
Ren G; Miao Z; Liu H; Jiang L; Limpa-Amara N; Mahmood A; Gambhir SS; Cheng Z
J Nucl Med; 2009 Oct; 50(10):1692-9. PubMed ID: 19759116
[TBL] [Abstract][Full Text] [Related]
30. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
[TBL] [Abstract][Full Text] [Related]
31. Uptake of [131I]thiouracil in tumours of patients with disseminated malignant melanoma. A pilot study.
Olander K; Larsson BS; Ringborg U; Schnell PO
Melanoma Res; 1992; 1(5-6):391-5. PubMed ID: 1422195
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
Desbois N; Gardette M; Papon J; Labarre P; Maisonial A; Auzeloux P; Lartigue C; Bouchon B; Debiton E; Blache Y; Chavignon O; Teulade JC; Maublant J; Madelmont JC; Moins N; Chezal JM
Bioorg Med Chem; 2008 Aug; 16(16):7671-90. PubMed ID: 18656367
[TBL] [Abstract][Full Text] [Related]
33. Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.
Chéhadé F; de Labriolle-Vaylet C; Moins N; Moreau MF; Papon J; Labarre P; Galle P; Veyre A; Hindié E
J Nucl Med; 2005 Oct; 46(10):1701-6. PubMed ID: 16204721
[TBL] [Abstract][Full Text] [Related]
34. [131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Kumar P; McQuarrie SA; Zhou A; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Aug; 32(6):647-53. PubMed ID: 16026712
[TBL] [Abstract][Full Text] [Related]
35. High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
Denoyer D; Greguric I; Roselt P; Neels OC; Aide N; Taylor SR; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2010 Mar; 51(3):441-7. PubMed ID: 20150254
[TBL] [Abstract][Full Text] [Related]
36. In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA).
Dittmann H; Coenen HH; Zölzer F; Dutschka K; Brandau W; Streffer C
Nucl Med Biol; 1999 Jan; 26(1):51-6. PubMed ID: 10096501
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma.
Billaud EM; Maisonial-Besset A; Rbah-Vidal L; Vidal A; Besse S; Béquignat JB; Decombat C; Degoul F; Audin L; Deloye JB; Dollé F; Kuhnast B; Madelmont JC; Tarrit S; Galmier MJ; Borel M; Auzeloux P; Miot-Noirault E; Chezal JM
Eur J Med Chem; 2015 Mar; 92():818-38. PubMed ID: 25637883
[TBL] [Abstract][Full Text] [Related]
38. Development of radioiodine-labeled 4-hydroxyphenylcysteamine for specific diagnosis of malignant melanoma.
Kobayashi M; Nishii R; Shikano N; Flores LG; Mizutani A; Ogai K; Sugama J; Nagamachi S; Kawai K
Nucl Med Biol; 2015 Jun; 42(6):536-40. PubMed ID: 25744361
[TBL] [Abstract][Full Text] [Related]
39. A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.
John CS; Bowen WD; Saga T; Kinuya S; Vilner BJ; Baumgold J; Paik CH; Reba RC; Neumann RD; Varma VM
J Nucl Med; 1993 Dec; 34(12):2169-75. PubMed ID: 8254405
[TBL] [Abstract][Full Text] [Related]
40. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
